đź“Š Evidence-Based Reference
vaginalis haemophilus
Los Angeles Biological Products
Summary: Vaginalis haemophilus is a device used in clinical settings for specific applications related to embolization-liquid-agents. Key evidence highlights its identification and differentiation from similar organisms.
FDA Clearance Information
Pathway
510K
Number
K790229 ↗
Decision Date
February 26, 1979
Product Code
JSH
Device Class
Class 1
Evidence
419 studies
The vaginalis haemophilus device was cleared through the FDA 510k pathway on February 26, 1979. It is manufactured by Los Angeles Biological Products and is classified as a Class 1 device.
What It Is
Vaginalis haemophilus is a clinical device used for the identification and differentiation of Haemophilus vaginalis in laboratory settings. It is intended for use in the context of embolization-liquid-agents.
Clinical Applications
This device is commonly used in clinical laboratories to identify Haemophilus vaginalis, particularly in cases where differentiation from similar organisms is necessary. It aids in the diagnosis of specific vaginal infections.
Evidence Summary
The literature includes 11 studies, primarily from the 1980s, focusing on the identification and pathogenicity of Haemophilus vaginalis. Study types include retrospective and prospective analyses.
Reported Outcomes
Published studies report that Haemophilus vaginalis can be identified using specific laboratory tests, with evidence supporting its role in certain vaginal infections. The studies emphasize the importance of accurate identification for clinical diagnosis.
Safety Profile
Reported complications include challenges in isolating the organism and differentiating it from similar bacteria. No direct adverse events related to the device itself are noted in the provided studies.
Evidence Limitations
The evidence is limited by the age of the studies, with most data originating from the 1980s. Further research is needed to update findings and confirm the device's efficacy and safety in current clinical practice.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for vaginalis haemophilus?
The device is indicated for the identification and differentiation of Haemophilus vaginalis in clinical laboratory settings.
What outcomes have been reported in clinical studies?
Studies report successful identification of Haemophilus vaginalis, aiding in the diagnosis of specific vaginal infections.
What complications have been reported?
Challenges in organism isolation and differentiation from similar bacteria have been reported, but no direct device-related adverse events are noted.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.